Close X
Tuesday, November 5, 2024
ADVT 
Health

CO2 Injections May Help Cut Belly Fat

IANS, 11 Jun, 2018 01:00 PM
    Fed up of trying to reduce belly fat? A weekly carbon dioxide gas-based therapy could be safe and effective in eliminating fat around the stomach, results of first clinical trials have shown.
     
     
    Carboxytherapy -- carbon dioxide gas injections -- could potentially be a new and non-invasive means of fat reduction.
     
     
    However, the changes were modest and did not result in long-term fat reduction, according to the paper published in the Journal of the American Academy of Dermatology.
     
    Carboxytherapy is a "safe, inexpensive gas, and injecting it into fat pockets may be preferred by patients who like natural treatments", said lead author Murad Alam, vice chair of dermatology at Northwestern University Feinberg School of Medicine. 
     
     
    While the way carboxytherapy works is not well understood, it is believed that injection of carbon dioxide causes changes in the microcirculation, and damages fat cells, he said.
     
     
    For the study, the team included a small set of adults who were not overweight and were randomised to get weekly carbon dioxide gas injection to one side of their abdomens and a sham treatment on the other side once a week for five weeks. 
     
     
    A high-resolution ultrasound detected a reduction in superficial fat after five weeks but not at 28 weeks. The patients' body weight did not change over the course of the study.
     
     
    That the difference was not maintained at six months suggests the treatment stimulated a temporary metabolic process that reduced the size of fat cells without inducing cell death, Alam said.
     
     
    "If carboxytherapy can provide prolonged benefits, it offers patients yet another noninvasive option for fat reduction," Alam said. 
     
     
    "But we don't feel it's ready for prime time...and it still needs to be optimised, though, so it's long lasting," he noted.

    MORE Health ARTICLES

    Living Kidney Donors Face Higher Health Risks During Later Pregnancies: Study

    Living Kidney Donors Face Higher Health Risks During Later Pregnancies: Study
    TORONTO — A new study says that women who have donated a kidney are at higher risk of developing gestational hypertension or a potentially dangerous condition called pre-eclampsia during pregnancies that follow the donation.

    Living Kidney Donors Face Higher Health Risks During Later Pregnancies: Study

    Over 400 cancer-causing 'hidden' faults detected in DNA

    Over 400 cancer-causing 'hidden' faults detected in DNA
    British scientists have discovered more than 400 "blind spots" in DNA which could hide cancer-causing gene faults....

    Over 400 cancer-causing 'hidden' faults detected in DNA

    Estrogen protects some women against heart disease

    Estrogen protects some women against heart disease
    Estrogens, also referred to as female sex hormones, have been thought to protect women from heart diseases and researchers have now found how they do so....

    Estrogen protects some women against heart disease

    How liver can improve diabetes management

    How liver can improve diabetes management
    Finding a way to stimulate glucose accumulation in the liver could help manage diabetes and obesity, shows a new research, paving the way for new...

    How liver can improve diabetes management

    Walnuts can slow down prostate cancer growth

    Walnuts can slow down prostate cancer growth
    “While they (walnuts) are high in fat, their fat does not drive prostate cancer growth. In fact, walnuts do just the opposite when fed to mice,” lead scientist and....

    Walnuts can slow down prostate cancer growth

    Tiny needles hold promise for two key eye diseases

    Tiny needles hold promise for two key eye diseases
    Needles too tiny to be seen with naked eyes can soon deliver drugs to specific areas relevant to two of the world's leading eye diseases - glaucoma and corneal....

    Tiny needles hold promise for two key eye diseases